Wilson's disease

Indian Journal of Pediatrics

Volumn 69, Issue 9, 2002, Pages 785-791

  Pandit, Anand ^a   Bavdekar, Ashish ^a   Bhave, Sheila ^a  

^a KEM HOSPITAL   (India)

Author keywords

Copper; Liver disease; Wilson's disease

Indexed keywords

CERULOPLASMIN; COPPER; COPPER 63; COPPER 65; ISOTOPE; PENICILLAMINE; TETRATHIOMOLYBDATE AMMONIUM; TRIENTINE; UNCLASSIFIED DRUG; ZINC;

ABDOMINAL PAIN; ANEMIA; AUTOIMMUNE DISEASE; BLEEDING; BONE MARROW DEPRESSION; CHELATION; CHROMOSOME 13; CLINICAL FEATURE; CONFERENCE PAPER; COPPER BLOOD LEVEL; DEPRESSION; DIET THERAPY; DRUG INDUCED DISEASE; DRUG MECHANISM; EARLY DIAGNOSIS; GENETIC SCREENING; HEAVY METAL POISONING; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER TOXICITY; LIVER TRANSPLANTATION; LONG TERM CARE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; PATHOGENESIS; PATIENT COMPLIANCE; PATIENT MONITORING; PROTEINURIA; THROMBOCYTOPENIA; TOXICITY; WILSON DISEASE;

EID: 0036709480     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723693     Document Type: Conference Paper

References (35)

1. Sass-Kortsak A. Wilson's disease. A treatable liver disease in children. Pediatr Clin North Am 1975; 22 : 963-984.
2. Pandit AN, Bhave SA. Problems in diagnosis and management of Wilson's disease in India. Indian Pediatr 1996; 33 : 807-811.
3. Bhave SA, Bavdekar AR, Pandit AN. Changing patterns of chronic liver disease in India. Indian J Pediatr 1994; 61 : 675-682.
4. Wilson SAK. Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver. Brain 1912; 34 : 295-509.
5. Kayser B. Ueber sinen Fall von angeborener grunlieher Verfarbung der Kornea. Klin Mbl Augenheilk 1902; 40 : 22-25.
6. Fleischer B, Zwei weitere Falle von grunliche Verfarbung der Kornea. Klin Mbl Augenheilk 1903; 41 : 489-491.
7. Cumings JN. The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration. Brain 1948; 71 : 410-415.
8. Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's Disease). Science 1952; 116 : 484-485.
9. Walshe JM. Penicillamine - A new oral therapy for Wilson's Disease. Am J Med 1956; 21 : 487-495.
10. Frydman F, Bonnie-Tamir B, Farrer A, Conneally PM, Magazanik A, Ashbel S, Goldwitch Z. Assignment of the gene for Wilson's disease to chromosome 13; Linkage to the esterase D lucus. Proc Natl Acand Sci U.S.A 1985; 82 : 1819-1821.
11. Petrukhin K, Fischer SG, Pirastu M et al. Mapping, cloning and genetic characterization on the region containing the Wilson's Disease gene. Nature Genet 1993; 5 : 338-343.
12. Tanzi RE, Petrukhin I, Chernov JL et al. The Wilson Disease, gene is a copper transporting ATPase with homology to the Menke's disease gene. Nature Genet 1993; 5 : 344-350.
13. Tanner MS. Wilson's Disease. Curr Pediatr 1991; 1 : 202-205.
14. Bhave SA, Purohit GM, Pradhan AM, Pandit AN. Hepatic presentation of Wilson's Disease. Indian Pediatr 1987; 24 : 385-393.
15. Sallie R, Chiyende J, Tan KC et al. Fulminant hepatic failure resulting from co-existing Wilson's disease and hepatitis E. Gut 1994; 35 : 849-853.
16. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson Disease. Medicine 1992; 71 No. 3 : 139-164.
17. Dastur DK, Manghani DK, Wadia NH. Wilson's Disease in India. Neurology 1968; 18 : 22-31.
18. nd edn. Philadelphia, Lippincott Williams & Wilkins, 2001; 595-640.
19. Bhave SA. Pediatric Wilson's Disease in India. Med J West India 1990; 8 : 14-18.
20. Yarze JC, Martin P, Munoz SJ, Friedmann LS. Wilson's Disease: Current Status. Am J Med 1992; 92 : 643-652.
21. Gregorio GV, Mieli-Vergani G. Urinary copper excretion after penicillamine challenge in children with prolonged hepatitis A infection. Hepatology 1993; 18 : 706-707.
22. Sternlieb I, Scheinberg IH. The role of radiocopper in the diagnosis of Wilson's Disease. Gastroenterotogy 1979; 77 : 138-142.
23. Ferenci P. Wilson's Disease. Indian J Gastroenterol 2001; 20 : S1; C71-C78.
24. McCullough AJ, Fleming CR, Thistle JL et al. Diagnosis of Wilson's Disease presenting as fulminant hepatic failure. Gastroenterology 1983; 84 : 161-167.
25. Berman DH, Leventhal RI, Gavaler JS et al. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterol 1991; 100 : 1129-1134.
26. Sallie R, Katsiyiannakis RI, Baldwin D et al. Failure of simple biochemical indices to reliably differentiate fulminant Wilson's Disease from other causes of fulminant hepatic failure. Hepatology 1992; 16 : 1206.
27. Linder MC, Maryam H. Copper biochemistry and molecular biology. In Uauy R, Olivares M, eds. Copper Nutrition in Humans : Essentiality and Toxicity. Am J Clin Nutr 1996; 63 : 797S-811S.
28. Harris ZL, Gitlin JD. Genetic and molecular basis for copper toxicity. In Uauy R, Olivares M, eds. Copper nutrition in humans: essentiality and toxicity. Am J Clin Nutr 1996; 63 : 836S-841S.
29. Brewer GJ, Johnson V, Dick RD, Kluin KJ, Fink JK, Brunberg JA. Treatment of Wilson disease with ammonium tetrathiomolybdate. Arch Neurol 1996; 53 : 1017-1025.
30. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V, Rick RD, Wang Y. Treatment of Wilson's Disease with Zinc: XII. Dose Regimen Requirements. Am J Med Sci 1993; 305 (4) : 199-202.
31. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of Neurological syndrome upon initial treatment of Wilson's Disease patients with penicillamine. Arch Neuro 1987; 44 : 490.
32. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease. Clinical presentation and use of prognostic index. Gut 1986; 27 : 1377-1381.
33. Walshe JM. Diagnosis and treatment of pre symptomatic Wilson's Disease. Lancet 1988; 2 : 435-437.
34. Thomas GR, Forbes JR, Robert EA et al. The Wilson Disease gene: Spectrum of mutations and their consequences. Nature Genet 1995; 9 : 210-217.
35. Maier-Dobersberger TH, Ferenci P, Polli C et al. The His1069Gln mutation in Wilson's disease: detection by a rapid PCR test, clinical course and liver biopsy findings. Ann Intern Med 1997; 127 : 21-26.